Clinically, breast cancer is diagnosed based on expression levels of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth receptor 2 (HER2), yielding three main types of breast cancer: ER+/PR+, HER2+, and triple-negative—each with its own treatment strategies and prognosis [2]. This evidence concerns the gene ERBB2 and breast carcinoma.